Pfizer has formed a strategic alliance with the National Institute for Health Research Clinical Research Network (NIHR CRN) as part of the company’s INSPIRE programme.
The US pharma firm selects preferred sites for clinical research through INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence). This is the first time an entire network has been invited to participate.
The aim is for the two organisations to share knowledge and experience of medicines research to help bring more clinical trials to the UK. It could mean that UK patients are among the first to benefit from new treatments.
Dame Sally Davies, chief medical officer for England, says: “I am delighted to see the excellent work of the NIHR Clinical Research Network being recognised by Pfizer. The UK has long played a pivotal role in researching and developing new medicines, benefiting patients around the world. This new partnership between is testament to the important role the Clinical Research Network plays in the battle against some of the most challenging diseases of our time.”
Pfizer has also selected the Greater Manchester Clinical Research Network to be part of the INSPIRE programme. The Network is the fourth site in the UK to be selected for the programme, joining locations in Newcastle, Scotland and the South West.